Photo highlights from ExL Pharma's September Conference: Merging eHR & EDC.
Participants from the pharmaceutical industry, HIT, EDC, NIH, and academia gathered in Washington, DC in September to explore, discuss, debate, and resolve present issues confronting and challenging the use of electronic health records (eHR) and electronic data capture (EDC) in clinical research.
Day One of ExL Pharma's "Merging eHR & EDC" Conference began with a hearty discussion of whether eHR and EDC can be merged. The discussion flowed well into Day Two's presentations on practical approaches to implementation and convergence.
Reaching Diverse Patient Populations With Personalized Treatment Methods
January 20th 2025Daejin Abidoye, head of solid tumors, oncology development, AbbVie, discusses a number of topics around diversity in clinical research including industry’s greatest challenges in reaching diverse patient populations, personalized treatment methods, recruitment strategies, and more.
STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo
January 17th 2025Semaglutide 7.2 mg significantly outperformed semaglutide 2.4 mg and placebo with a 20.7% average reduction in weight and a comparable safety and tolerability profile, further establishing its efficacy in obesity treatment.